Results 81 to 90 of about 1,761 (189)

Analysing the effect of multidisciplinary teams to address preventive healthcare gaps in a rural teaching clinic: a quality improvement project

BMJ Open Quality
Preventive care decreases the risk of illness, disease and death, yet patient adherence to preventive care is low, calculated to be around 5%, and rural residents are suspected to have even lower rates compared with urban patients.
Veronica Hill, Brittany Woody, Fahad Irfan Abid, Meaghan Barros, Priya Pohani   +4 more
doaj   +1 more source

Shingrix Education for Providers

, 2019
Shingles is a prevalent disease within the overall population, and incidence in North America continues to increase. Shingles is commonly found in older adults 60 years of age and older and can recur two or three times. Shingrix was released in 2017 as a
Buzzeo, Lindsey Hanks
core  

An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix compared to Varilrix

, 2018
Clinical trials covering the immunogenicity of a vaccine aim to study the longitudinal dynamics of certain immune cells after vaccination. The corresponding immunogenicity datasets are mainly analyzed by the use of statistical (mixed effects) models ...
Pierre Van Damme, Benson Ogunjimi, Nina Keersmaekers, Philippe Beutels, Niel Hens   +4 more
core   +1 more source

Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy

Vaccines
Background: A nudge intervention against Herpes Zoster, created and implemented in Italy, is presented in order to administer the Shingrix vaccine on a sample of frail patients, as required by the National Prevention Plan.
Francesco De Caro, Francesca Malatesta, Nadia Pecoraro, Mario Capunzo, Luna Carpinelli, Simona Caruccio, Giuseppina Cersosimo, Maria Costantino, Claudio Giordano, Walter Longanella, Vincenzo Patella, Arcangelo Saggese Tozzi, Giulia Savarese, Pio Sinopoli, Emilia Anna Vozzella, Giuseppina Moccia   +15 more
doaj   +1 more source

Comparative Cytokine and Histology Studies on HPV and Other Viral Vaccinations: No Pathogenicity of HPV Vaccine Adjuvants

Cancer Science, Volume 116, Issue 12, Page 3309-3325, December 2025.
Anti‐HPV vaccine activists claimed that aluminum (Al) adjuvants in HPV vaccines could cause immune abnormalities, leading to neurological diseases. We evaluated the cytokine and histology profiles following administrations of HPV vaccines and other viral vaccines containing adjuvants.
Reona Shiro, Fumitaka Sato, Seiichi Omura, Ah‐Mee Park, Cong Thanh Nguyen, Ijaz Ahmad, Sandesh Rimal, Koji Kinoshita, Noriomi Matsumura, Ikuo Tsunoda   +9 more
wiley   +1 more source

Shingrix: Educating Patients on the New Shingles Vaccine

, 2018
Herpes zoster (shingles) is a viral infection that results in a painful rash and has a myriad of long-term complications, including post-herpetic neuralgia- chronic pain that does not resolved despite resolution of the rash.
Jost, Sarah Natasha
core  

Availability of Shingrix Vaccine in St. Albans and its Benefits vs Zostavax

, 2019
Across the United States, including St. Albans, Vermont, a shortage of Shingrix Vaccine has left many patients without effective protection from shingles.
Hussein, Ibrahim Sobhi-Luther
core  

Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses

npj Vaccines
Herpes zoster (HZ), also known as shingles, is caused by the reactivation of latent varicella-zoster virus (VZV). Decreased VZV-specific T-cell immune responses significantly contribute to the development of HZ.
Soo-Kyung Jeong, Su-Jin Ham, Seung-Hee Baek, Eun-Jung Jung, Hyun-Jin Jo, Hye-Ran Cha, Jae-Myun Lee, Byung Cheol Ahn, Jung Sun Yum, Eunyoung Chun   +9 more
doaj   +1 more source

Shingles Vaccine: Identifying high risk groups in the IBD clinic setting

, 2019
Title: Shingles Vaccine: Identifying high risk groups in the IBD clinic setting Background: The Inflammatory Bowel Disease (IBD) population is an immunocompromised patient population who is at risk for Herpes Zoster (HZ) due to their medication regimen ...
Barajas, Crystal
core   +1 more source

Bibliometric analysis and visualization mapping of herpes zoster vaccine publications from 1999 to 2024

Frontiers in Medicine
BackgroundHerpes Zoster (HZ) is a viral skin disease caused by reactivation of latent Varicella Zoster Virus (VZV) in human ganglia, presenting with unilateral neuropathic pain and vesicular rash.
Wenli Gao, Dongyang Gao, Lin Li, Juan Li, Xinyi Yao, Junling Zhang   +5 more
doaj   +1 more source